<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36075961</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2058-5276</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Nature microbiology</Title><ISOAbbreviation>Nat Microbiol</ISOAbbreviation></Journal><ArticleTitle>Rational attenuation of RNA viruses with zinc finger antiviral protein.</ArticleTitle><Pagination><StartPage>1558</StartPage><EndPage>1567</EndPage><MedlinePgn>1558-1567</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41564-022-01223-8</ELocationID><Abstract><AbstractText>Attenuation of a virulent virus is a proven approach for generating vaccines but can be unpredictable. For example, synonymous recoding of viral genomes can attenuate replication but sometimes results in pleiotropic effects that confound rational vaccine design. To enable specific, conditional attenuation of viruses, we examined target RNA features that enable zinc finger antiviral protein (ZAP) function. ZAP recognized CpG dinucleotides and targeted CpG-rich RNAs for depletion, but RNA features such as CpG numbers, spacing and surrounding nucleotide composition that enable specific modulation by ZAP were undefined. Using synonymously mutated HIV-1 genomes, we defined several sequence features that govern ZAP sensitivity and enable stable attenuation. We applied rules derived from experiments with HIV-1 to engineer a mutant enterovirus A71 genome whose attenuation was stable and strictly ZAP-dependent, both in cell culture and in mice. The conditionally attenuated enterovirus A71 mutant elicited neutralizing antibodies that were protective against wild-type enterovirus A71 infection and disease in mice. ZAP sensitivity can thus be readily applied for the rational design of conditionally attenuated viral vaccines.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gon&#xe7;alves-Carneiro</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9333-1540</Identifier><AffiliationInfo><Affiliation>Laboratory of Retrovirology, The Rockefeller University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mastrocola</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory of Retrovirology, The Rockefeller University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-8641-7824</Identifier><AffiliationInfo><Affiliation>Laboratory of Retrovirology, The Rockefeller University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DaSilva</LastName><ForeName>Justin</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6393-0000</Identifier><AffiliationInfo><Affiliation>Laboratory of Retrovirology, The Rockefeller University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Yoke Fun</ForeName><Initials>YF</Initials><Identifier Source="ORCID">0000-0001-7089-0510</Identifier><AffiliationInfo><Affiliation>Department of Medical Microbiology, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bieniasz</LastName><ForeName>Paul D</ForeName><Initials>PD</Initials><Identifier Source="ORCID">0000-0002-2368-3719</Identifier><AffiliationInfo><Affiliation>Laboratory of Retrovirology, The Rockefeller University, New York, NY, USA. pbieniasz@rockefeller.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, The Rockefeller University, New York, NY, USA. pbieniasz@rockefeller.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI050111</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 AI150470</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 AI170660</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>HHMI</Acronym><Agency>Howard Hughes Medical Institute</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Microbiol</MedlineTA><NlmUniqueID>101674869</NlmUniqueID><ISSNLinking>2058-5276</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015497" MajorTopicYN="Y">HIV-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="Y">Viral Vaccines</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016335" MajorTopicYN="N">Zinc Fingers</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36075961</ArticleId><ArticleId IdType="pmc">PMC9519448</ArticleId><ArticleId IdType="doi">10.1038/s41564-022-01223-8</ArticleId><ArticleId IdType="pii">10.1038/s41564-022-01223-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gao G, Guo X, Goff SP. Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science. 2002;297:1703&#x2013;1706. doi: 10.1126/science.1074276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1074276</ArticleId><ArticleId IdType="pubmed">12215647</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller S, et al. Inhibition of filovirus replication by the zinc finger antiviral protein. J. Virol. 2007;81:2391&#x2013;2400. doi: 10.1128/JVI.01601-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01601-06</ArticleId><ArticleId IdType="pmc">PMC1865956</ArticleId><ArticleId IdType="pubmed">17182693</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y-T, et al. Human cytomegalovirus evades ZAP detection by suppressing CpG dinucleotides in the major immediate early 1 gene. PLoS Pathog. 2020;16:e1008844. doi: 10.1371/journal.ppat.1008844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008844</ArticleId><ArticleId IdType="pmc">PMC7498042</ArticleId><ArticleId IdType="pubmed">32886716</ArticleId></ArticleIdList></Reference><Reference><Citation>Takata MA, et al. CG dinucleotide suppression enables antiviral defence targeting non-self RNA. Nature. 2017;550:124&#x2013;127. doi: 10.1038/nature24039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24039</ArticleId><ArticleId IdType="pmc">PMC6592701</ArticleId><ArticleId IdType="pubmed">28953888</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard AJ, Bijker EM. A guide to vaccinology: from basic principles to new developments. Nat. Rev. Immunol. 2021;21:83&#x2013;100. doi: 10.1038/s41577-020-00479-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00479-7</ArticleId><ArticleId IdType="pmc">PMC7754704</ArticleId><ArticleId IdType="pubmed">33353987</ArticleId></ArticleIdList></Reference><Reference><Citation>le Nou&#xeb;n C, et al. Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimization. Proc. Natl Acad. Sci. USA. 2014;111:13169&#x2013;13174. doi: 10.1073/pnas.1411290111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1411290111</ArticleId><ArticleId IdType="pmc">PMC4246931</ArticleId><ArticleId IdType="pubmed">25157129</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai Y-H, et al. Enterovirus A71 containing codon-deoptimized VP1 and high-fidelity polymerase as next-generation vaccine candidate. J. Virol. 2019;93:e02308&#x2013;e02318. doi: 10.1128/JVI.02308-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02308-18</ArticleId><ArticleId IdType="pmc">PMC6580961</ArticleId><ArticleId IdType="pubmed">30996087</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, et al. Zika virus attenuation by codon pair deoptimization induces sterilizing immunity in mouse models. J. Virol. 2018;92:e00701&#x2013;e00718. doi: 10.1128/JVI.00701-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00701-18</ArticleId><ArticleId IdType="pmc">PMC6096834</ArticleId><ArticleId IdType="pubmed">29925661</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller S, et al. Live attenuated influenza virus vaccines by computer-aided rational design. Nat. Biotechnol. 2010;28:723&#x2013;726. doi: 10.1038/nbt.1636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1636</ArticleId><ArticleId IdType="pmc">PMC2902615</ArticleId><ArticleId IdType="pubmed">20543832</ArticleId></ArticleIdList></Reference><Reference><Citation>Eschke K, Trimpert J, Osterrieder N, Kunec D. Attenuation of a very virulent Marek&#x2019;s disease herpesvirus (MDV) by codon pair bias deoptimization. PLoS Pathog. 2018;14:e1006857&#x2013;e1006857. doi: 10.1371/journal.ppat.1006857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006857</ArticleId><ArticleId IdType="pmc">PMC5805365</ArticleId><ArticleId IdType="pubmed">29377958</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves-Carneiro, D., Bieniasz, P. D., Berkhout, B. &amp; Prasad, V. R. Mechanisms of attenuation by genetic recoding of viruses. mBio12, e02238&#x2013;20 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8545087</ArticleId><ArticleId IdType="pubmed">33402534</ArticleId></ArticleIdList></Reference><Reference><Citation>Tulloch F, Atkinson NJ, Evans DJ, Ryan MD, Simmonds P. RNA virus attenuation by codon pair deoptimisation is an artefact of increases in CpG/UpA dinucleotide frequencies. eLife. 2014;3:e04531. doi: 10.7554/eLife.04531.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.04531</ArticleId><ArticleId IdType="pmc">PMC4383024</ArticleId><ArticleId IdType="pubmed">25490153</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves-Carneiro D, Takata MA, Ong H, Shilton A, Bieniasz PD. Origin and evolution of the zinc finger antiviral protein. PLoS Pathog. 2021;17:e1009545. doi: 10.1371/journal.ppat.1009545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009545</ArticleId><ArticleId IdType="pmc">PMC8102003</ArticleId><ArticleId IdType="pubmed">33901262</ArticleId></ArticleIdList></Reference><Reference><Citation>Meagher JL, et al. Structure of the zinc-finger antiviral protein in complex with RNA reveals a mechanism for selective targeting of CG-rich viral sequences. Proc. Natl Acad. Sci. USA. 2019;116:24303&#x2013;24309. doi: 10.1073/pnas.1913232116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1913232116</ArticleId><ArticleId IdType="pmc">PMC6883784</ArticleId><ArticleId IdType="pubmed">31719195</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X, et al. Molecular mechanism of RNA recognition by zinc-finger antiviral protein. Cell Rep. 2020;30:46&#x2013;52.e4. doi: 10.1016/j.celrep.2019.11.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.11.116</ArticleId><ArticleId IdType="pubmed">31914396</ArticleId></ArticleIdList></Reference><Reference><Citation>Ficarelli M, et al. CpG dinucleotides inhibit HIV-1 replication through zinc finger antiviral protein (ZAP)- J. Virol. 2022;94:e01337&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158733</ArticleId><ArticleId IdType="pubmed">31748389</ArticleId></ArticleIdList></Reference><Reference><Citation>le Nou&#xeb;n C, et al. Optimization of the codon pair usage of human respiratory syncytial virus paradoxically resulted in reduced viral replication in vivo and reduced immunogenicity. J. Virol. 2020;94:e01296&#x2013;19. doi: 10.1128/JVI.01296-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01296-19</ArticleId><ArticleId IdType="pmc">PMC6955273</ArticleId><ArticleId IdType="pubmed">31666376</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayakawa S, et al. ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses. Nat. Immunol. 2011;12:37&#x2013;44. doi: 10.1038/ni.1963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1963</ArticleId><ArticleId IdType="pubmed">21102435</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenbaum BD, Levine AJ, Bhanot G, Rabadan R. Patterns of evolution and host gene mimicry in influenza and other RNA viruses. PLoS Pathog. 2008;4:e1000079. doi: 10.1371/journal.ppat.1000079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000079</ArticleId><ArticleId IdType="pmc">PMC2390760</ArticleId><ArticleId IdType="pubmed">18535658</ArticleId></ArticleIdList></Reference><Reference><Citation>le Nou&#xeb;n C, et al. Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure. Proc. Natl Acad. Sci. USA. 2017;114:E386&#x2013;E395. doi: 10.1073/pnas.1619242114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1619242114</ArticleId><ArticleId IdType="pmc">PMC5255620</ArticleId><ArticleId IdType="pubmed">28049853</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns CC, et al. Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region. J. Virol. 2006;80:3259&#x2013;3272. doi: 10.1128/JVI.80.7.3259-3272.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.7.3259-3272.2006</ArticleId><ArticleId IdType="pmc">PMC1440415</ArticleId><ArticleId IdType="pubmed">16537593</ArticleId></ArticleIdList></Reference><Reference><Citation>Zell R. Picornaviridae&#x2014;the ever-growing virus family. Arch. Virol. 2018;163:299&#x2013;317. doi: 10.1007/s00705-017-3614-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-017-3614-8</ArticleId><ArticleId IdType="pubmed">29058149</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee HK, Zainol MI, Sam I-C, Chan YF. Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis. Expert Rev. Anti Infect. Ther. 2021;19:733&#x2013;747. doi: 10.1080/14787210.2021.1851194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2021.1851194</ArticleId><ArticleId IdType="pubmed">33183118</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Tee HK, Lee MHP, Sam I-C, Chan YF. Enterovirus A71 DNA-launched infectious clone as a robust reverse genetic tool. PLoS ONE. 2016;11:e0162771. doi: 10.1371/journal.pone.0162771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0162771</ArticleId><ArticleId IdType="pmc">PMC5019408</ArticleId><ArticleId IdType="pubmed">27617744</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee HK, et al. Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice. PLoS Pathog. 2019;15:e1007863. doi: 10.1371/journal.ppat.1007863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007863</ArticleId><ArticleId IdType="pmc">PMC6881073</ArticleId><ArticleId IdType="pubmed">31730673</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MHP, et al. Vaccine candidates generated by codon and codon pair deoptimization of enterovirus A71 protect against lethal challenge in mice. Vaccine. 2021;39:1708&#x2013;1720. doi: 10.1016/j.vaccine.2021.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.02.024</ArticleId><ArticleId IdType="pubmed">33640144</ArticleId></ArticleIdList></Reference><Reference><Citation>Caine EA, Moncla LH, Ronderos MD, Friedrich TC, Osorio JE. A single mutation in the VP1 of Enterovirus 71 is responsible for increased virulence and neurotropism in adult interferon-deficient mice. J. Virol. 2016;90:8592&#x2013;8604. doi: 10.1128/JVI.01370-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01370-16</ArticleId><ArticleId IdType="pmc">PMC5021399</ArticleId><ArticleId IdType="pubmed">27440896</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih C, et al. Immunocompetent and immunodeficient mouse models for Enterovirus 71 pathogenesis and therapy. Viruses. 2018;10:674. doi: 10.3390/v10120674.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10120674</ArticleId><ArticleId IdType="pmc">PMC6316343</ArticleId><ArticleId IdType="pubmed">30487421</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, et al. Structure of N-terminal domain of ZAP indicates how a zinc-finger protein recognizes complex RNA. Nat. Struct. Mol. Biol. 2012;19:430&#x2013;435. doi: 10.1038/nsmb.2243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2243</ArticleId><ArticleId IdType="pubmed">22407013</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. Stable stem enabled Shannon entropies distinguish non-coding RNAs from random backgrounds. BMC Bioinformatics. 2012;13:S1. doi: 10.1186/1471-2105-13-S5-S1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-13-S5-S1</ArticleId><ArticleId IdType="pmc">PMC3358654</ArticleId><ArticleId IdType="pubmed">22537005</ArticleId></ArticleIdList></Reference><Reference><Citation>Ficarelli M, et al. KHNYN is essential for the zinc finger antiviral protein (ZAP) to restrict HIV-1 containing clustered CpG dinucleotides. eLife. 2019;8:e46767. doi: 10.7554/eLife.46767.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.46767</ArticleId><ArticleId IdType="pmc">PMC6615859</ArticleId><ArticleId IdType="pubmed">31284899</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez D, et al. Sequence, structure, and context preferences of human RNA binding proteins. Mol. Cell. 2018;70:854&#x2013;867.e9. doi: 10.1016/j.molcel.2018.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.05.001</ArticleId><ArticleId IdType="pmc">PMC6062212</ArticleId><ArticleId IdType="pubmed">29883606</ArticleId></ArticleIdList></Reference><Reference><Citation>Floyd-Smith G, Slattery E, Lengyel P. Interferon action: RNA cleavage pattern of a (2&#x2032;-5&#x2032;)oligoadenylate-dependent endonuclease. Science. 1981;212:1030&#x2013;1032. doi: 10.1126/science.6165080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.6165080</ArticleId><ArticleId IdType="pubmed">6165080</ArticleId></ArticleIdList></Reference><Reference><Citation>Wreschner DH, McCauley JW, Skehel JJ, Kerr IM. Interferon action&#x2014;sequence specificity of the ppp(A2&#x2032;p)nA-dependent ribonuclease. Nature. 1981;289:414&#x2013;417. doi: 10.1038/289414a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/289414a0</ArticleId><ArticleId IdType="pubmed">6162102</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaunt E, et al. Elevation of CpG frequencies in influenza A genome attenuates pathogenicity but enhances host response to infection. eLife. 2016;5:e12735. doi: 10.7554/eLife.12735.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.12735</ArticleId><ArticleId IdType="pmc">PMC4798949</ArticleId><ArticleId IdType="pubmed">26878752</ArticleId></ArticleIdList></Reference><Reference><Citation>Yew NS, et al. CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo. Mol. Ther. 2002;5:731&#x2013;738. doi: 10.1006/mthe.2002.0598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mthe.2002.0598</ArticleId><ArticleId IdType="pubmed">12027557</ArticleId></ArticleIdList></Reference><Reference><Citation>Faust SM, et al. CpG-depleted adeno-associated virus vectors evade immune detection. J. Clin. Investig. 2013;123:2994&#x2013;3001. doi: 10.1172/JCI68205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI68205</ArticleId><ArticleId IdType="pmc">PMC3696560</ArticleId><ArticleId IdType="pubmed">23778142</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo G, Burge CB. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 2004;11:377&#x2013;394. doi: 10.1089/1066527041410418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/1066527041410418</ArticleId><ArticleId IdType="pubmed">15285897</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves-Carneiro D, McKeating JA, Bailey D. The measles virus receptor SLAMF1 can mediate particle endocytosis. J. Virol. 2017;91:e02255&#x2013;16. doi: 10.1128/JVI.02255-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02255-16</ArticleId><ArticleId IdType="pmc">PMC5355598</ArticleId><ArticleId IdType="pubmed">28100610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrike M, et al. Functional role of type I and type II interferons in antiviral defense. Science. 1994;264:1918&#x2013;1921. doi: 10.1126/science.8009221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8009221</ArticleId><ArticleId IdType="pubmed">8009221</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberatore RA, et al. Rhabdo-immunodeficiency virus, a murine model of acute HIV-1 infection. eLife. 2019;8:e49875. doi: 10.7554/eLife.49875.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.49875</ArticleId><ArticleId IdType="pmc">PMC6874478</ArticleId><ArticleId IdType="pubmed">31644426</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>